4.8 Article

CAR-T cells and CAR-Tregs targeting conventional type-1 dendritic cell suppress experimental autoimmune encephalomyelitis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation

Emma Proics et al.

Summary: This publication reports the preclinical characterization of Tregs transduced with a CAR lentiviral vector. The results demonstrated the specificity, immunosuppressive function, and safety of the transduced Tregs. The study also showed that the transduced Tregs effectively prevented graft-versus-host disease in mice and remained stable without switching to a proinflammatory phenotype. Furthermore, concomitant tacrolimus did not impair the survival or inhibitory function of the transduced Tregs.

GENE THERAPY (2023)

Review Oncology

Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion

Leila Amini et al.

Summary: Chimeric antigen receptor (CAR) T cell therapy is an effective treatment for certain hematological cancers. Successful CAR-T cell infusion requires timely preparation and consideration of various factors. This review provides a summary of the considerations in preparing patients for CAR-T cell therapy and highlights current limitations and future research areas.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Review Medicine, Research & Experimental

Applying a clinical lens to animal models of CAR-T cell therapies

Brynn B. Duncan et al.

Summary: Chimeric antigen receptor (CAR)-T cells are a promising treatment for various cancers. However, animal models have limitations in accurately predicting the behavior of engineered T cells in humans, and more research is needed to optimize these models.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2022)

Article Cardiac & Cardiovascular Systems

Cross-Priming Dendritic Cells Exacerbate Immunopathology After Ischemic Tissue Damage in the Heart

Elvira Forte et al.

Summary: After ischemic injury to the heart, cross-priming dendritic cells play a role in activating cytotoxic CD8(+) T cells by presenting self-antigens from necrotic cardiac cells. Research suggests that activation of cytotoxic CD8(+) T cells by cross-priming DC may exacerbate inflammatory damage of the myocardium and corresponding decline in cardiac function.

CIRCULATION (2021)

Review Immunology

Cross talk between human regulatory T cells and antigen-presenting cells: Lessons for clinical applications

Christine M. Wardell et al.

Summary: Regulatory T cells (Tregs) play a crucial role in maintaining self-tolerance and immune homeostasis. The interaction between Tregs and antigen-presenting cells (APCs) is essential for optimizing Treg-based therapeutic approaches in treating autoimmune diseases.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

Article Multidisciplinary Sciences

Priming of myelin-specific T cells in the absence of dendritic cells results in accelerated development of Experimental Autoimmune Encephalomyelitis

Thaiphi Luu et al.

Summary: This study investigated the role of dendritic cells (DCs) in the development of autoimmune disease, particularly in relation to self-reactive CD4(+) T cells in multiple sclerosis (MS). The findings indicate that DC deficiency can reduce immune tolerance to self-antigens, such as PLP, leading to accelerated onset of EAE. Additionally, non-DC cells were shown to effectively present CNS myelin antigens to self-reactive T cells in the absence of DCs, exacerbating EAE.

PLOS ONE (2021)

Review Immunology

Emerging Therapeutics for Immune Tolerance: Tolerogenic Vaccines, T cell Therapy, and IL-2 Therapy

Cody D. Moorman et al.

Summary: This article discusses the current status of autoimmune diseases, the standard treatments, and potential future directions for therapy. The focus is on three main areas of research in immune tolerance: tolerogenic vaccines, T cell therapies, and IL-2 therapies aiming at expanding regulatory T cells.

FRONTIERS IN IMMUNOLOGY (2021)

Article Cell Biology

Depleting plasmacytoid dendritic cells reduces local type I interferon responses and disease activity in patients with cutaneous lupus

Jodi L. Karnell et al.

Summary: Plasmacytoid dendritic cells (pDCs) are specialized in producing IFN and regulating immune responses, with persistent activation in autoimmune diseases. VIB7734, a monoclonal antibody, effectively depletes pDCs, reduces IFN activity, and improves clinical disease activity in animal models and patients. Biomarker analysis suggests that VIB7734 may be more effective in individuals with high baseline IFN activity, supporting further development in IFN-associated diseases.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Review Immunology

Engineered Cytokine Signaling to Improve CAR T Cell Effector Function

Matthew Bell et al.

Summary: CAR T cell therapy is effective for hematological malignancies, but there is a need to improve its efficacy for solid tumors and brain tumors. Several approaches are being pursued to enhance the antitumor activity of CAR T cells, including augmenting signal 3 of T cell activation and improving the function of CAR T cells in the tumor microenvironment.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Intestinal cDC1 drive cross-tolerance to epithelial-derived antigen via induction of FoxP3+ CD8+ Tregs

Thorsten Joeris et al.

Summary: The study revealed that peripheral cross-tolerance to intestinal epithelial cell (IEC)-derived antigen involves the generation and suppressive function of FoxP3(+)CD8(+) T cells, which requires the involvement of intestinal cDC1. Factors such as PD-L1, TGF beta, and retinoic acid contribute to the generation of gut-tropic CCR9(+)CD103(+)FoxP3(+)CD8(+) T-regs. CD103 deficiency in CD8(+) T cells results in a lack of tolerogenic activity in vivo.

SCIENCE IMMUNOLOGY (2021)

Article Immunology

Type 1 conventional dendritic cells and interferons are required for spontaneous CD4+ and CD8+ T-cell protective responses to breast cancer

Raphael Mattiuz et al.

Summary: Interferons and cDC1 are critical for breast cancer immunosurveillance. IFN-gamma plays a prominent role over IFN-I in licensing cDC1 for efficient T-cell activation. High intratumor expression of genes specific to cDC1, CTLs, CD4(+) T cells, or IFN responses is associated with a better prognosis in breast cancer patients.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2021)

Review Immunology

The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses

Jorge A. Soto et al.

FRONTIERS IN IMMUNOLOGY (2020)

Article Cell Biology

Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells

Nicholas A. J. Dawson et al.

SCIENCE TRANSLATIONAL MEDICINE (2020)

Article Immunology

cDC1 are required for the initiation of collagen-induced arthritis

Maria Ines Ramos et al.

JOURNAL OF TRANSLATIONAL AUTOIMMUNITY (2020)

Review Immunology

Dendritic cells in cancer immunology and immunotherapy

Stefanie K. Wculek et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Immunology

Dendritic cell subsets in T cell programming: location dictates function

S. C. Eisenbarth

NATURE REVIEWS IMMUNOLOGY (2019)

Article Allergy

Critical role of plasmacytoid dendritic cells in induction of oral tolerance

Tomofumi Uto et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2018)

Article Medicine, Research & Experimental

CNS-resident classical DCs play a critical role in CNS autoimmune disease

David A. Giles et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Review Oncology

Engineering CAR-T cells

Cheng Zhang et al.

BIOMARKER RESEARCH (2017)

Article Biochemistry & Molecular Biology

Gatekeeper role of brain antigen-presenting CD11c+ cells in neuroinflammation

Magdalena Paterka et al.

EMBO JOURNAL (2016)

Article Immunology

IDO-orchestrated crosstalk between pDCs and Tregs inhibits autoimmunity

Carla Lippens et al.

JOURNAL OF AUTOIMMUNITY (2016)

Article Immunology

pDC therapy induces recovery from EAE by recruiting endogenous pDC to sites of CNS inflammation

Fernanda V. Duraes et al.

JOURNAL OF AUTOIMMUNITY (2016)

Review Medicine, General & Internal

Human autoimmune diseases: a comprehensive update

Lifeng Wang et al.

JOURNAL OF INTERNAL MEDICINE (2015)

Review Immunology

CD8+ T-Cells as Immune Regulators of Multiple Sclerosis

Sushmita Sinha et al.

FRONTIERS IN IMMUNOLOGY (2015)

Article Immunology

Predominant role of plasmacytoid dendritic cells in stimulating systemic autoimmunity

Xinfang Huang et al.

FRONTIERS IN IMMUNOLOGY (2015)

Editorial Material Primary Health Care

What's new in multiple sclerosis?

Lilia G. Dimitrov et al.

BRITISH JOURNAL OF GENERAL PRACTICE (2014)

Article Immunology

Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model

Sarah L. Rowland et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2014)

Article Neurosciences

Treg cells mediate recovery from EAE by controlling effector T cell proliferation and motility in the CNS

Michail Koutrolos et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2014)

Article Immunology

Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE

Magnus Isaksson et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2012)

Review Immunology

CD4+FOXP3+ T Regulatory Cells in Human Autoimmunity: More Than a Numbers Game

S. Alice Long et al.

JOURNAL OF IMMUNOLOGY (2011)

Article Biochemical Research Methods

Active immunization induces toxicity of diphtheria toxin in diphtheria resistant mice - Implications for neuroinflammatory models

Gerd Meyer Zu Hoerste et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2010)

Article Immunology

Feedback control of regulatory T cell homeostasis by dendritic cells in vivo

Guillaume Darrasse-Jeze et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2009)

Article Immunology

Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease

Katharina Lahl et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2007)

Article Biochemistry & Molecular Biology

Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis

M Greter et al.

NATURE MEDICINE (2005)